KALV — Kalvista Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Kalvista Pharmaceuticals, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2021 April 30th	2022 April 30th	2023 April 30th	2024 April 30th	2025 April 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	249	166	149	210	221
Net Total Receivables	10.4	14.1	18.6	10.9	4.14
Prepaid Expenses
Total Current Assets	264	194	172	226	242
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.55	10	10.8	9.15	7.53
Other Long Term Assets
Total Assets	272	204	183	235	251
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.77	11.6	15	22.8	45.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.8	18.8	22.2	28.8	155
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	257	185	161	207	95.4
Total Liabilities & Shareholders' Equity	272	204	183	235	251
Total Common Shares Outstanding